logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ESMO 2018 – Adding radium-223 to abiraterone associated with poorer outcomes in mCRPC

Trial reports more fractures and more deaths in patients given radium-223 in addition to abiraterone